All News

Found 2,921 articles

• Roche's Mabthera Receives Positive Opinion In Europe For Treating Patients Whose Chronic Lymphocytic Leukaemia Returns

  7/24/2009

• Trimeris, Inc. Reports Second Quarter 2009 FUZEON(R) Sales Results

  7/23/2009

• DxS Ltd's TheraScreen(R) K-RAS Companion Diagnostic Approved for Use With Amgen's Vectibix(TM) in Canada

  7/13/2009

• DiagnoCure Announces Second Quarter Financial Results

  6/9/2009

• Roche: IMPACT Study Showed Longer Valcyte(R) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

  6/2/2009

• Response Biomedical Announces Terms of Unit Offering

  5/8/2009

• Lipoxen Release: Positive Phase I Clinical Trial Results for ErepoXen

  5/6/2009

• Inimex Pharmaceuticals Inc. Begins First Clinical Study of an Innate Defense Regulator

  4/28/2009

• Roche, InterMune, Inc., And Pharmasset, Inc. Announce: Ground-Breaking Combination Of All-Oral Agents Demonstrates Potential As Hepatitis C Treatment Regimen

  4/27/2009

• TRANSGENE Presents Additional Phase I Data For TG4040 In Hepatitis C Chronically Infected Patients At EASL And Is Now Preparing For Phase II Trial

  4/24/2009

• InterMune, Inc. and Pharmasset, Inc. to Discuss INFORM-1 Results From EASL Conference, April 25

  4/21/2009

• Response Biomedical Delivers Record Preliminary Revenues in First Quarter

  4/20/2009

• Trimeris, Inc. Reports First Quarter 2009 FUZEON(R) Sales Results

  4/16/2009

• Response Biomedical Reports 2008 Financial Results

  3/30/2009

• Genentech, Inc. (JOBS), Biogen Idec, Inc. (Massachusetts) (JOBS) Say Rituxan Fails in Lupus Study

  3/12/2009

• TRANSGENE Reports Full Year Results 2008

  3/10/2009

• Roche (JOBS) Gets EU Approval for Mabthera for Leukaemia

  2/27/2009

• A Roche Sequencing Study Reveals New Insights in Drug Resistance and Tropism Associated with the New HIV Integrase and Entry Inhibitor Therapy Classes

  2/18/2009

• Response Biomedical Announces Funded Development Program with Roche Diagnostics Corporation to Expand Cardiovascular Product Offerings

  2/12/2009

• Trimeris, Inc. Reports Fourth Quarter 2008 FUZEON(R) Sales Results

  2/4/2009